These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11220560)

  • 1. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil.
    Meurling CJ; Ingemansson MP; Roijer A; Carlson J; Lindholm CJ; Smideberg B; Sornmo L; Stridh M; Olsson SB
    Europace; 1999 Oct; 1(4):234-41. PubMed ID: 11220560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG.
    Bollmann A; Sonne K; Esperer HD; Toepffer I; Klein HU
    Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):92-7. PubMed ID: 12049679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation.
    Pandozi C; Bianconi L; Calò L; Castro A; Lamberti F; Scianaro MC; Gentilucci G; Santini M
    J Am Coll Cardiol; 2000 Dec; 36(7):2234-41. PubMed ID: 11127466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous MgSO4 alone and in combination with glucose, insulin and potassium (GIK) prolong the atrial cycle length in chronic atrial fibrillation.
    Ingemansson MP; Smideberg B; Olsson SB
    Europace; 2000 Apr; 2(2):106-14. PubMed ID: 11225936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation.
    Ramanna H; Elvan A; Wittkampf FH; de Bakker JM; Hauer RN; Robles de Medina EO
    J Am Coll Cardiol; 2001 Apr; 37(5):1403-7. PubMed ID: 11300453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-dependent effect of verapamil on atrial refractoriness.
    Hassan SA; Oral H; Scharf C; Chugh A; Pelosi F; Knight BP; Strickberger SA; Morady F
    J Am Coll Cardiol; 2003 Feb; 41(3):446-51. PubMed ID: 12575974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
    Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans.
    Daoud EG; Knight BP; Weiss R; Bahu M; Paladino W; Goyal R; Man KC; Strickberger SA; Morady F
    Circulation; 1997 Sep; 96(5):1542-50. PubMed ID: 9315545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive assessment of atrial fibrillation (AF) cycle length in man: potential application for studying AF.
    Meurling CJ; Sörnmo L; Stridh M; Olsson SB
    Ann Ist Super Sanita; 2001; 37(3):341-9. PubMed ID: 11889950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method.
    Holm M; Pehrson S; Ingemansson M; Sörnmo L; Johansson R; Sandhall L; Sunemark M; Smideberg B; Olsson C; Olsson SB
    Cardiovasc Res; 1998 Apr; 38(1):69-81. PubMed ID: 9683908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length.
    Meurling CJ; Roijer A; Waktare JE; Holmqvist F; Lindholm CJ; Ingemansson MP; Carlson J; Stridh M; Sörnmo L; Olsson SB
    BMC Cardiovasc Disord; 2006 Mar; 6():11. PubMed ID: 16533393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal variations of the dominant cycle length of chronic atrial fibrillation.
    Meurling CJ; Waktare JE; Holmqvist F; Hedman A; Camm AJ; Olsson SB; Malik M
    Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H401-6. PubMed ID: 11123257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillatory frequency, atrial fibrillatory rate, or atrial cycle length--does it matter?
    Bollmann A; Husser D; Olsson SB
    Am J Cardiol; 2004 Jul; 94(1):147. PubMed ID: 15219531
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the atrial rate as a factor modulating ventricular response during atrial fibrillation.
    Climent AM; Guillem MS; Husser D; Castells F; Millet J; Bollmann A
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1510-7. PubMed ID: 20636310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring.
    Niwano S; Fukaya H; Sasaki T; Hatakeyama Y; Fujiki A; Izumi T
    Europace; 2007 Dec; 9(12):1209-15. PubMed ID: 17897926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological restoration and maintenance of sinus rhythm by antiarrhythmic agents].
    Sugi K
    J Cardiol; 1999 Mar; 33 Suppl 1():59-64. PubMed ID: 10342138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillatory rate in the clinical context: natural course and prediction of intervention outcome.
    Platonov PG; Corino VD; Seifert M; Holmqvist F; Sörnmo L
    Europace; 2014 Nov; 16 Suppl 4():iv110-iv119. PubMed ID: 25362161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation.
    Ingemansson MP; Holm M; Olsson SB
    Heart; 1998 Jul; 80(1):71-6. PubMed ID: 9764064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and clinical application of time-frequency analysis of atrial fibrillation electrocardiograms.
    Husser D; Stridh M; Cannom DS; Bhandari AK; Girsky MJ; Kang S; Sörnmo L; Bertil Olsson S; Bollmann A
    J Cardiovasc Electrophysiol; 2007 Jan; 18(1):41-6. PubMed ID: 17229299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.